Nuclear and echocardiographic imaging for prediction of reversible left ventricular ischemic dysfunction after coronary revascularization: Current status and future directions

Journal of Cardiovascular Pharmacology

Volumn 28, Issue SUPPL. 1, 1996, Pages

  Vanoverschelde, Jean Louis J ^a,b   Gerber, Bernhard ^a   Pasquet, Agnès ^a   Melin, Jacques A ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Coronary artery disease; Echocardiographic imaging; Left ventricular dysfunction; Nuclear imaging

Indexed keywords

THALLIUM 201;

CONFERENCE PAPER; CORONARY ARTERY BYPASS SURGERY; ECHOCARDIOGRAPHY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; IMAGE ANALYSIS; LIGHT SCATTERING; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0029789883     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199600003-00005     Document Type: Conference Paper

References (56)

1. Emond M, Mock MB, Davis KB, et al. Long-term survival of medically-treated patients in the Coronary Artery Surgery Study (CASS) registry. Circulation 1994;90:2645-57.
2. Alderman EL, Fisher LD, Litwin P, et al. Results of coronary artery bypass surgery in patients with poor left ventricular function (CASS). Circulation 1983;68:785-95.
3. Eitzman D, Al-Aouar Z, Kanter HL, et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 1992;20:559-65.
4. Lee KS, Marwick TH, Cook SA, et al. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization. Circulation 1994;90:2687-94.
5. Di Carli MF, Davidson M, Little R, et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994;73:527-33.
6. Tennant R, Wiggers CJ. The effects of coronary occlusion on myocardial contraction. Am J Physiol 1935;112:351-61.
7. Heyndrickx GR, Millard RW, McRitchie RJ, Maroko PR, Vatner SF. Regional myocardial functional and electrophysiological alterations after brief coronary occlusions in conscious dogs. J Clin Invest 1975;56:978-85.
8. Bolli R. Myocardial "stunning" in man. Circulation 1992;86:1671-91.
9. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989;117:211-21.
10. Vanoverschelde JLJ, Wijns W, Depré C, et al. Mechanisms of chronic regional postischemic dysfunction in humans: new insights from the study of non-infarcted collateral dependent myocardium. Circulation 1993;87:1513-23.
11. Depré C, Vanoverschelde J-L, Melin JA, et al. Structural and metabolic correlates of the reversibility of chronic left ventricular ischemic dysfunction in humans. Am J Physiol 1995;268:H1265-73.
12. Borgers M, Thoné F, Wouters L, Ausma J, Shivalkar B, Flameng W. Structural correlates of regional myocardial dysfunction in patients with critical coronary artery stenosis: chronic hibernation? Cardiovasc Pathol 1993;2:237-45.
13. Melin JA, Becker LC. Quantitative relationship between global left ventricular thallium uptake and blood flow: effects of propranolol, ouabaine, dipyridamole and coronary occlusion. J Nucl Med 1986;27:641-52.
14. Melin JA, Wijns W, Keyeux A, et al. Assessment of thalHum-201 redistribution versus glucose uptake as predictors of viability after coronary occlusion and reperfusion. Circulation 1988;77:927-34.
15. Gewirtz H, Beller GA, Strauss HW, et al. Transient defects of resting thallium scans in patients with coronary disease. Circulation 1979;59:707-13.
16. Berger BC, Watson DD, Burwell LR, et al. Redistribution of thallium at rest in patients with stable and unstable angina and the effects of coronary artery bypass graft surgery. Circulation 1979;60:1114-25.
17. Iskandrian AS, Hakki aH, Kane SA, et al. Rest and redistribution thallium-201 myocardial scintigraphy to predict improvement in left ventricular function after coronary artery bypass grafting. Am J Cardiol 1983;51:1312-6.
18. Mori T, Minamiji K, Kurogane H, Ogawa K, Yoshida Y. Rest-injected Thallium-201 imaging for assessing viability of severe asynergic regions. J Nucl Med 1991;32:1718-24.
19. 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 1993;87:1630-41.
20. Marzullo P, Parodi O, Reisenhofer B, et al. Value of rest thallium-201/technetium-99m sestamibi scans and dobutamine echocardiography for detecting myocardial viability. Am J Cardiol 1993;71:166-72.
21. Alfieri O, La Canna G, Giubbini R, Perdini A, Zogno M, Fucci C. Recovery of myocardial function: the ultimate target of coronary revascularization. Eur J CardioThorax Surg 1993;7:325-30.
22. Dilsizian V, Rocco TP, Freedman NM, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress redistribution imaging. N Engl J Med 1990;323:141-6.
23. Ohtani H, Tamaki N, Yonekura Y, et al. Value of thallium-201 reinjection after delayed SPECT imaging for predicting reversible ischemia after coronary artery bypass graft. Am J Cardiol 1990;66:394-9.
24. Zimmerman R, Mall G, Rauch B, et al. Residual 201-Tl activity in irreversible defects as a marker of myocardial viability. Clinicopathological studies. Circulation 1995;91:1016-21.
25. Vanoverschelde J-L, Gerber BL, Marwick T, D'Hondt A-M, Wijns W, Melin JA. Direct comparison of thallium SPECT with dobutamine echocardiography for delineation of myocardial viability. J Nucl Med 1995;36:120P.
26. Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884-8.
27. Tamaki N, Yonekura Y, Yamashita K, et al. Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol 1989;64:860-5.
28. Marwick TH, MacIntyre WJ, Lafont A, Nemec JJ, Salcedo EE. Metabolic responses of hibernating and infarcted myocardium to revascularization. A follow-up study of regional perfusion, function and metabolism. Circulation 1992;85:1347-53.
29. Gropler RJ, Geltman EM, Sampathkumaran K, et al. Com- parison of carbon-11-acetate with fluorine-18-fluoro-deoxyglucose for delineating viable myocardium by positron emission tomography. J Am Coll Cardiol 1993;22:1587-97.
30. Knuuti J, Saraste M, Nuutila P, et al. Myocardial viability: fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization. Am Heart J 1994;127:785-96.
31. vom Dahl J, Eitzman DT, Al-Aouar ZR, et al. Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization. Circulation 1994;90:2356-66.
32. Tamaki N, Kawamoto M, Tadamura E, et al. Prediction of reversible ischemia after revascularization. Perfusion and metabolic studies with positron emission tomography. Circulation 1995;91:1697-705.
33. Grandin C, Wijns W, Melin JA, et al. Delineation of myocardial viability with positron emission tomography: incremental value of quantitative flow and metabolic assessment for identification of reversible dysfunction after coronary revascularization. J Nucl Med 1995;36:1543-52.
34. Schwaiger M, Brunken R, Grover-McKay M, et al. Regional myocardial metabolism in patients with acute myocardial infarction assessed by positron emission tomography. J Am Coll Cardiol 1986;8:800-8.
35. Piérard LA, De Landsheere CM, Berthe C, Rigo P, Kulbertus HE. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. J Am Coll Cardiol 1990;15:1021-3.
36. Gropler RJ, Siegel BA, Sampathkumaran K, et al. Dependence of recovery of contractile function on maintenance of oxidative metabolism after myocardial infarction. J Am Coll Cardiol 1992;19:989-97.
37. de Silva R, Yamomoto Y, Rhodes CG, et al. Preoperative prediction of the outcome of coronary revascularization using positron emission tomography. Circulation 1992;86:1738-42.
38. Nesto RW, Cohn LH, Collins JJ, Wynne J, Holman L, Cohn PF. Inotropic contractile reserve: a useful predictor of increased 5-year survival and improved postoperative left ventricular function in patients with coronary artery disease and reduced ejection fraction. Am J Cardiol 1982;50:39-44.
39. Barilla F, Gheorghiade M, Alam M, Khaja F, Goldstein S. Low-dose dobutamine in patients with acute myocardial infarction identifies viable but not contractile myocardium and predicts the magnitude of improvement in wall motion abnormalities in response to coronary revascularization. Am Heart J 1991;122:1522-31.
40. Previtali M, Poli A, Lanzarini L, Fetiveau R, Mussini A, Ferrario M. Dobutamine stress echocardiography for assessment of myocardial viability and ischemia in acute myocardial infarction treated with thrombolysis. Am J Cardiol 1993;72:124G-30G.
41. Watada H, Ito H, Oh H, et al. Dobutamine stress echocardiography predicts reversible dysfunction and quantitates the extent of irreversibly damaged myocardium after reperfusion of anterior myocardial infarction. J Am Coll Cardiol 1995;24:624-30.
42. Smart SC, Sawada S, Ryan T, et al. Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation 1993;88:405-15.
43. Cigarroa CG, deFilippi CR, Brickner E, Alvarez LG, Wait MA, Grayburn PA. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation 1993;88:430-6.
44. La Canna G, Alfieri O, Giubbini R, Gargano M, Ferrari R, Visioli O. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with coronary artery disease. J Am Coll Cardiol 1994;23:617-26.
45. Perrone-Filardi P, Pace L, Prastaro M, et al. Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease. Circulation 1995;91:2556-65.
46. 201Tl single photon emission computed tomography. Circulation 1995;91:2748-52.
47. Afridi I, Kleiman NS, Raizner AE, Zoghbi WA. Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 1995;91:663-70.
48. Vanoverschelde J-L, Gerber BL, D'Hondt A-M, et al. Preoperative selection of patients with severely impaired left ventricular function for coronary revascularization: role of low-dose dobutamine echocardiography and exercise-redistribution-reinjection thallium SPECT. Circulation 1995;92:11-37-44.
49. 201thallium SPECT and positron emission tomography. Which test for the prediction of myocardial viability? [Abstract]. Circulation 1994;90:I-314.
50. Burst RW, Perkins OW, Oppenheim BE, et al. Direct comparison of fluorine-18 FDG SPECT, fluorine-18 FDG PET and rest thallium-201 SPECT for detection of myocardial viability. J Nucl Med 1995;36:176-9.
51. DeCoster PM, Wijns W, Cauwe F, Robert A, Beckers C, Melin JA. Area-at-risk determination by technetium-99m-hexakis-2-methoxyisobutyl isonitrile in experimental reperfused myocardial infarction. Circulation 1990;82:2152-62.
52. Wackers FJT, Gibbons RJ, Verani MS, et al. Serial quantitative planar technetium-99m isonitrile imaging in acute myocardial infarction: efficacy for noninvasive assessment of thrombolytic therapy. J Am Coll Cardiol 1989;14:861-73.
53. 99mTc-sestamibi. Circulation 1994;89:2552-61.
54. Camarano G, Ragosta M, Grimple LW, Powers ER, Kaul S. Identification of viable myocardium with myocardial contrast echocardiography in patients with poor left ventricular systolic function caused by recent or remote myocardial infarction. Am J Cardiol 1995;75:215-9.
55. Milunski MR, Mohr GA, Wear KA, Sobel BE, Miller JG, Wickline SA. Early identification with ultrasonic integrated backscatter of viable but stunned myocardium in dogs. J Am Coll Cardiol 1989;14:462-71.
56. Milunski MR, Mohr GA, Pérez JE, et al. Ultrasonic tissue characterization with integrated backscatter. Acute myocardial ischemia, reperfusion, and stunned myocardium in patients. Circulation 1989;80:491-503.